Gotham Asset Management LLC Lowers Stake in CME Group Inc (CME)

Gotham Asset Management LLC decreased its position in shares of CME Group Inc (NASDAQ:CME) by 38.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,666 shares of the financial services provider’s stock after selling 4,726 shares during the period. Gotham Asset Management LLC’s holdings in CME Group were worth $1,442,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Resources Investment Advisors Inc. lifted its stake in CME Group by 2,800.0% in the 4th quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares during the last quarter. Ruggie Capital Group bought a new position in CME Group in the 4th quarter valued at approximately $28,000. Smith Asset Management Group LP lifted its stake in CME Group by 200.0% in the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 100 shares during the last quarter. Nelson Roberts Investment Advisors LLC bought a new position in CME Group in the 4th quarter valued at approximately $33,000. Finally, Athena Capital Advisors LLC bought a new position in CME Group in the 4th quarter valued at approximately $43,000. Institutional investors and hedge funds own 84.84% of the company’s stock.

Several equities analysts recently commented on the stock. Citigroup set a $205.00 price objective on shares of CME Group and gave the company a “buy” rating in a research note on Friday, February 15th. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Thursday, January 31st. JPMorgan Chase & Co. started coverage on shares of CME Group in a research note on Friday, February 15th. They set an “underweight” rating and a $164.00 price target for the company. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday. Finally, ValuEngine downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $192.00.

In other CME Group news, COO Julie Holzrichter sold 4,362 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $182.45, for a total value of $795,846.90. Following the completion of the sale, the chief operating officer now directly owns 41,265 shares in the company, valued at $7,528,799.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $182.90, for a total transaction of $36,580.00. Following the transaction, the director now owns 3,600 shares of the company’s stock, valued at $658,440. The disclosure for this sale can be found here. Insiders sold 28,489 shares of company stock valued at $4,948,996 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.

NASDAQ:CME traded down $0.56 during trading hours on Friday, reaching $176.36. The company had a trading volume of 2,021,786 shares, compared to its average volume of 1,617,974. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $63.10 billion, a price-to-earnings ratio of 25.86, a PEG ratio of 3.60 and a beta of 0.29. CME Group Inc has a twelve month low of $153.90 and a twelve month high of $197.08.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.02. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The business’s quarterly revenue was up 37.4% on a year-over-year basis. During the same period last year, the company posted $1.12 earnings per share. Equities analysts predict that CME Group Inc will post 6.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, March 8th were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.70%. This is a boost from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date was Thursday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

ILLEGAL ACTIVITY WARNING: “Gotham Asset Management LLC Lowers Stake in CME Group Inc (CME)” was originally reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/21/gotham-asset-management-llc-lowers-holdings-in-cme-group-inc-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: What is the downside to momentum investing?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.